India mandates registration of all ethics committees reviewing drug, device trials
This article was originally published in Clinica
Executive Summary
All ethics committees operating in India that review and approve protocols for drug or medical device trials have 45 days to register with the Central Drugs Standard Control Organization under new rules finalized by the government on 8 February.